Isometric diagram of a glowing teal helical peptide ribbon docking into a G-protein-coupled receptor in a membrane with a cyclic-AMP burst inside the cell, representing a GHRH-analog reference compound
Mindful Research

Sermorelin as a GHRH-Analog Reference Compound (In Vitro)

Updated By: Mindful Research Team1 min read

Key takeaways

  • Sermorelin is a GHRH-analog reference compound modeled on growth-hormone-releasing hormone.
  • It engages the GHRH receptor, a G-protein-coupled receptor, in cell models.
  • It is characterized with receptor-binding and cell-based signaling assays (e.g. cyclic AMP).
  • It serves as a benchmark for comparing other GHRH-analog compounds.
  • Supplied as a research material for in vitro research use only.

Sermorelin is a GHRH-analog reference compound: it is modeled on growth-hormone-releasing hormone and is studied in vitro for its engagement of the GHRH receptor. This profile describes the compound and its study.

What is sermorelin?

Sermorelin is a synthetic peptide modeled on a fragment of growth-hormone-releasing hormone (GHRH). It is described here only by structure and molecular target, as a laboratory material.

The GHRH receptor

The GHRH receptor is a G-protein-coupled receptor. As a GHRH analog, sermorelin engages this receptor in cell models, which is the basis for its use as a reference compound.

How it is characterized in vitro

Researchers use receptor-binding and cell-based signaling assays (such as cyclic AMP) in cells expressing the GHRH receptor to characterize sermorelin's engagement. A worked example of the design, using the full-length analog, is in GHRH-receptor binding and cAMP assay design for tesamorelin.

Why it is a useful reference

A well-characterized GHRH analog is a convenient benchmark when comparing other GHRH-analog compounds in a controlled system.

Related research guides

Research-use note

Sermorelin is supplied as a research material for in vitro research use only. It is not for human or animal use.

Related research: Enclomiphene.

Frequently asked questions

What is sermorelin?

A synthetic peptide modeled on a fragment of growth-hormone-releasing hormone (GHRH), studied in vitro as a GHRH-analog reference compound. View Sermorelin

What receptor does it engage?

The GHRH receptor, a G-protein-coupled receptor, in cell models.

How is it characterized in vitro?

With receptor-binding and cell-based signaling assays such as cyclic AMP in cells expressing the GHRH receptor.

Why is it a useful reference?

A well-characterized GHRH analog is a convenient benchmark for comparing other GHRH-analog compounds.

Research use only?

Yes, in vitro laboratory research use only.

Continue reading

Vial of blue copper-complex lyophilized peptide powder in a cold-storage block, representing KLOW 80 mg handling and stabilityKLOW 80 mg: Copper-Complex Blue Lyophilized Powder, Handling, Stability and Stock Concentration Math The KLOW 80 mg vial is a pale-blue lyophilized powder because one of its four components, GHK-Cu, is a copper(II) complex; reconstituted... Researcher in a lab coat checking a vial of blue peptide blend powder against a four-peak analytical readoutSourcing KLOW as a Research Material: Per-Component COA and Purity Sourcing KLOW as a research material means obtaining, in one Certificate of Analysis, the identity and purity data for all four of... Two vials of blue peptide blend powder side by side, one with an extra tripeptide render, representing GLOW versus KLOWGLOW vs KLOW: What KPV Adds to the Blend (Composition Comparison) The difference between GLOW and KLOW is one component: KLOW adds 10 mg of the tripeptide KPV (Lys-Pro-Val, CAS 67727-97-3) to GLOW's...